#United States #Birmingham #Health Equity #Acclinate #Vet100

Acclinate Recognized as a Fast-Growing Veteran-Owned Business

Acclinate, a key player in the realm of inclusive clinical research and community health engagement, has proudly secured a position on the Vet100 list for 2025. This annual ranking celebrates the fastest-growing companies owned by veterans across the United States. The accolade, conferred by the Institute for Veterans and Military Families (IVMF) in partnership with Inc. magazine, underlines notable achievements in growth, leadership, and impactful contributions throughout various sectors.

Commitment to Health Equity

This honor serves as a testament to Acclinate's commitment to promoting health equity and trust within communities through innovative technology and engagement strategies. As the need for diverse representation in clinical research continues to grow, Acclinate's business model exemplifies how sustainable growth can harmoniously align with impactful outreach.

Veteran Leadership at the Core

At the helm of Acclinate is CEO and Co-Founder Del Smith, PhD, an Air Force veteran whose military service has profoundly influenced his understanding of responsibility, integrity, and the necessity of inclusive systems. “Being recognized in the Vet100 is significant as it encapsulates the values instilled in me during my service: harmony, discipline, and the idea that success is a collective effort,” Smith remarked. He further emphasized how Acclinate's team embodies purpose-driven action and empathetic leadership.

Harnessing Trust and Technology

The recognition from Vet100 emphasizes Acclinate’s role as a reliable ally to sponsors and contract research organizations (CROs) aiming for equitable research practices. The organization's unique approach, branded as “Touch + Tech,” fuses a consistent community presence with the e-DICT™ analytics platform. This model not only enriches the collaboration between pharmaceutical firms and community resources but also equips them with essential insights and relationships to enhance the representation in clinical studies.

As regulatory bodies and community stakeholders increasingly prioritize health equity, Acclinate’s award underscores its mission-driven ethos, proving that companies devoted to their causes can grow responsibly while elevating industry standards. Moreover, Acclinate is determined to ensure that diverse perspectives are integral in shaping clinical research, aiming to reflect real world demographics accurately.

About Acclinate

Acclinate is dedicated to transforming health access and equity via community involvement and inclusive research methodologies. Through platforms such as NOWINCLUDED and e-DICT™, Acclinate aids pharmaceutical organizations and healthcare institutions in cultivating trust, enhancing trial diversity, and conducting research that mirrors the diverse tapestry of society.

Moreover, the company continues to innovate, as evidenced by upcoming projects designed to deepen community engagement and further advance the cause of health equity. In an industry where disparities in health outcomes persist, the establishment of robust channels of communication and collaboration is critical. Acclinate stands at the forefront, driving change that is not only needed but imperative.

In summary, Acclinate’s acknowledgment as a fastest-growing veteran-led business reflects more than just success in numbers—it signifies a movement towards inclusivity and diversified representation in healthcare research. With leaders like Del Smith guiding the charge, the future looks promising for equitable health practices across the nation.

For further information, connect with Acclinate’s marketing team under Lauren Clements at [email protected] or via phone at 256-435-2800.